Article
Calreticulin Mutations in Myeloproliferative Neoplasms: Comparison of Three Diagnostic Methods.
PloS one - 1 Jan 2015
Park Ji-Hye, Sevin Margaux, Ramla Selim, Truffot Aurélie, Verrier Tiffany, Bouchot Dominique, Courtois Martine, Bas Mathilde, Benali Sonia, Bailly François, Favre Bernardine, Guy Julien, Martin Laurent, Maynadié Marc, Carillo Serge, Girodon François
Abstract excerpt
Calreticulin (CALR) mutations have recently been reported in 70-84% of JAK2V617F-negative myeloproliferative neoplasms (MPN), and this detection has become necessary to improve the diagnosis of MPN. In a large single-centre cohort of 298 patients suffering from Essential Thrombocythemia (ET), the JAK2V617F, CALR and MPL mutations were noted in 179 (60%), 56 (18.5%) and 13 (4.5%) respectively. For the detection of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
